Loading clinical trials...
Loading clinical trials...
Comparative Effect of Tocilizumab Versus Methotrexate on Major Adverse Cardiovascular Events in Giant Cell Arteritis: A Nationwide Target Trial Emulation Using the French SNDS
Conditions
Locations
2
France
APHP_ Hôpital Saint-Antoine
Paris, France
APHP_ Hôpital Pitié-Salpêtrière
Paris, France
Start Date
January 1, 2012
Primary Completion Date
December 31, 2024
Completion Date
December 31, 2024
Last Updated
March 9, 2026
NCT07547098
NCT07246577
NCT07491315
NCT07487363
NCT07256249
NCT06909773
Lead Sponsor
Groupe français d'étude des Maladies Inflammatoires de loeil
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions